<font color="red">Spotty_1</font> <font color="red">calcification_1</font> as a marker of <font color="red">accelerated_1</font> <font color="red">progression_2</font> <font color="red">of_1</font> <font color="red">coronary_2</font> <font color="red">atherosclerosis_2</font> <font color="red">:_2</font> insights from serial intravascular ultrasound . 
<br>
<br> OBJECTIVES The purpose of this study was to determine <font color="red">atheroma_1</font> <font color="red">progression_1</font> in patients with <font color="red">spotty_1</font> <font color="red">calcification_1</font> <font color="red">._1</font> 
<br> BACKGROUND Although extensively calcified <font color="red">atherosclerotic_1</font> <font color="red">lesions_1</font> have been proposed to be clinically quiescent , the presence of <font color="red">spotty_1</font> <font color="red">calcification_1</font> within plaque has been reported to be associated with an <font color="red">increased_1</font> <font color="red">incidence_2</font> <font color="red">of_2</font> <font color="red">ischemic_2</font> <font color="red">cardiovascular_2</font> <font color="red">events_2</font> <font color="red">._2</font> The relationship between <font color="red">spotty_1</font> <font color="red">calcification_1</font> <font color="red">and_1</font> <font color="red">disease_1</font> <font color="red">progression_1</font> has not been investigated . 
<br> METHODS A total of 1,347 stable patients with angiographic coronary artery disease underwent <font color="red">serial_1</font> <font color="red">evaluation_2</font> <font color="red">of_1</font> <font color="red">atheroma_2</font> <font color="red">burden_2</font> <font color="red">with_1</font> <font color="red">intravascular_2</font> <font color="red">ultrasound_2</font> <font color="red">imaging_2</font> <font color="red">._2</font> Patients with <font color="red">spotty_1</font> <font color="red">calcification_1</font> were identified based on the presence of <font color="red">lesions_1</font> <font color="red">(_1</font> <font color="red">1_1</font> <font color="red">to_1</font> <font color="red">4_1</font> <font color="red">mm_1</font> <font color="red">in_1</font> <font color="red">length_1</font> <font color="red">)_1</font> <font color="red">containing_1</font> <font color="red">an_1</font> <font color="red">arc_1</font> <font color="red">of_1</font> <font color="red">calcification_1</font> <font color="red">of_1</font> <font color="red"><_1</font> <font color="red">90°._1</font> <font color="red">Clinical_2</font> <font color="red">characteristics_2</font> <font color="red">and_2</font> <font color="red">disease_2</font> <font color="red">progression_2</font> were compared between patients with <font color="red">spotty_1</font> <font color="red">calcification_1</font> ( n = 922 ) and those with <font color="red">no_1</font> <font color="red">calcification_1</font> ( n = 425 ) . 
<br> RESULTS Patients with <font color="red">spotty_3</font> <font color="red">calcification_3</font> <font color="red">were_1</font> <font color="red">older_3</font> <font color="red">(_1</font> <font color="red">age_1</font> <font color="red">56_1</font> <font color="red">years_1</font> <font color="red">vs._1</font> <font color="red">54_1</font> <font color="red">years_1</font> <font color="red">;_1</font> <font color="red">p_1</font> <font color="red">=_1</font> <font color="red">0.001_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">more_1</font> <font color="red">likely_1</font> <font color="red">to_1</font> <font color="red">be_1</font> <font color="red">male_1</font> <font color="red">(_1</font> <font color="red">68%_1</font> <font color="red">vs._1</font> <font color="red">54%_1</font> <font color="red">;_1</font> <font color="red">p_1</font> <font color="red">=_1</font> <font color="red">0.01_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">have_1</font> <font color="red">a_1</font> <font color="red">history_2</font> <font color="red">of_2</font> <font color="red">diabetes_4</font> <font color="red">mellitus_4</font> <font color="red">(_1</font> <font color="red">30%_1</font> <font color="red">vs._1</font> <font color="red">24%_1</font> <font color="red">;_1</font> <font color="red">p_1</font> <font color="red">=_1</font> <font color="red">0.01_1</font> <font color="red">)_1</font> <font color="red">and_1</font> <font color="red">myocardial_3</font> <font color="red">infarction_3</font> <font color="red">(_1</font> <font color="red">28%_1</font> <font color="red">vs._1</font> <font color="red">20%_1</font> <font color="red">;_1</font> <font color="red">p_1</font> <font color="red">=_1</font> <font color="red">0.004_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">have_1</font> <font color="red">lower_3</font> <font color="red">on_4</font> <font color="red">-_4</font> <font color="red">treatment_4</font> <font color="red">high_4</font> <font color="red">-_4</font> <font color="red">density_4</font> <font color="red">lipoprotein_4</font> <font color="red">cholesterol_4</font> <font color="red">levels_4</font> ( 48 ± 16 mg / dl vs. 51 ± 17 mg / dl ; p = 0.001 ) . Patients with spotty calcification demonstrated a <font color="red">greater_1</font> <font color="red">percent_1</font> <font color="red">atheroma_3</font> <font color="red">volume_3</font> <font color="red">(_3</font> <font color="red">PAV_3</font> <font color="red">)_3</font> ( 36.0 ± 7.6% vs. 29.0 ± 8.5% ; p < 0.001 ) and <font color="red">total_2</font> <font color="red">atheroma_2</font> <font color="red">volume_2</font> ( 174.6 ± 71.9 mm(3 ) vs. 133.9 ± 64.9 mm(3 ) ; p < 0.001 ) . On serial evaluation , <font color="red">spotty_1</font> <font color="red">calcification_1</font> was associated with <font color="red">greater_3</font> <font color="red">progression_4</font> <font color="red">of_4</font> <font color="red">PAV_4</font> ( + 0.43 ± 0.07% vs. + 0.02 ± 0.11% ; p = 0.002 ) . Although <font color="red">intensive_1</font> <font color="red">low_1</font> <font color="red">-_1</font> <font color="red">density_1</font> <font color="red">lipoprotein_1</font> <font color="red">cholesterol_1</font> and <font color="red">blood_1</font> <font color="red">pressure_1</font> <font color="red">lowering_1</font> therapy slowed <font color="red">disease_2</font> <font color="red">progression_2</font> <font color="red">,_2</font> these efficacies were attenuated in patients with <font color="red">spotty_1</font> <font color="red">calcification_1</font> <font color="red">._1</font> 
<br> CONCLUSIONS The presence of <font color="red">spotty_1</font> <font color="red">calcification_1</font> is associated with <font color="red">more_2</font> <font color="red">extensive_2</font> <font color="red">and_2</font> <font color="red">diffuse_2</font> <font color="red">coronary_3</font> <font color="red">atherosclerosis_3</font> <font color="red">and_2</font> <font color="red">accelerated_2</font> <font color="red">disease_2</font> <font color="red">progression_2</font> despite use of medical therapies .